Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Clinical Outcomes of EBV-Positive Compared to EBV-Negative Diffuse Large B Cell Lymphoma in the Modern Era

Kristen McClellan, Cheryl Chang, Anivarya Kumar, John Hsu, Samantha M Thomas, Jie Wang

Blood (2024) 144 (Supplement 1): 3088.

https://doi.org/10.1182/blood-2024-198231

Published: 2024

Journal Articles

Longitudinal detection of prion infection in preclinical sheep blood samples compared using 3 assays

Charlotte M. Thomas, M. Khalid F. Salamat, Florian Almela, Jillian K. Cooper, Kaetan Ladhani, Mark E. Arnold, Daisy Bougard, Olivier Andréoletti, E. Fiona Houston

Blood (2024) 144 (18): 1962–1973.

https://doi.org/10.1182/blood.2024024649

Published: 2024

Includes: Supplemental data

Journal Articles

PATH-HHT, a Double-Blind, Randomized, Placebo-Controlled Trial in Hereditary Hemorrhagic Telangiectasia Demonstrates That Pomalidomide Reduces Epistaxis and Improves Quality of Life

Blood (2023) 142 (Supplement 2): LBA-3.

https://doi.org/10.1182/blood-2023-191983

Published: 2023

Journal Articles

Risk Assessing Medical Inpatients for Hospital-Acquired Venous Thrombosis: The Medical Inpatients Thrombosis and Hemostasis (MITH) Study

Neil A. Zakai, Insu Koh, Katherine Wilkinson, Nicholas S Roetker, Andrew D Sparks, Allen B Repp, Ryan M Thomas, Nicholas L Smith, Chris E. Holmes, Mary Cushman

Blood (2021) 138 (Supplement 1): 829.

https://doi.org/10.1182/blood-2021-152584

Published: 2021

Journal Articles

Impaired adhesion of neutrophils expressing Slc44a2/HNA-3b to VWF protects against NETosis under venous shear rates

Gaïa Zirka, Philippe Robert, Julia Tilburg, Victoria Tishkova, Chrissta X. Maracle, Paulette Legendre, Bart J. M. van Vlijmen, Marie-Christine Alessi, Peter J. Lenting, Pierre-Emmanuel Morange, Grace M. Thomas

Blood (2021) 137 (16): 2256–2266.

https://doi.org/10.1182/blood.2020008345

Published: 2021

Includes: Multimedia, Supplemental data

Journal Articles

Development of a Computable Phenotype for Hospital-Acquired Venous Thrombosis: The Medical Inpatient Thrombosis and Hemostasis (MITH) Study

Ryan M Thomas, MD, Insu Koh, PhD, Katherine Wilkinson, MS, Nicholas Roetker, PhD, Nicholas L Smith, PhD, Allen B Repp, MD, Chris E. Holmes, MD PhD, Timothy B Plante, MD MHS, Mary Cushman, MD, Neil A. Zakai, MDMSc

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-141047

Published: 2020

Journal Articles

Identification and targeting of novel CDK9 complexes in acute myeloid leukemia

Elspeth M. Beauchamp, Sameem M. Abedin, Sara G. Radecki, Mariafausta Fischietti, Ahmet Dirim Arslan, Gavin T. Blyth, Angela Yang, Connor Lantz, Alissa Nelson, Young Ah Goo, Imo Akpan, Elizabeth A. Eklund, Olga Frankfurt, Eleanor N. Fish, Paul M. Thomas, Jessica K. Altman, Leonidas C. Platanias

Blood (2019) 133 (11): 1171–1185.

https://doi.org/10.1182/blood-2018-08-870089

Published: 2019

Includes: Supplemental data

Journal Articles

Treatment with Foscarnet after Allogeneic Hematopoietic-Cell Transplant (AlloHCT) Is Associated with Long-Term Loss of Renal Function

Yevgeniya Foster, MD, Michael J Grant, MD, Samantha M Thomas, MS, Blake Cameron, MD MBI, Doug Raiff, PharmD, BCPS, Kelly Corbet, B.S., Christopher Ferreri, MD, Mitchell E. Horwitz, MD

Blood (2018) 132 (Supplement 1): 4594.

https://doi.org/10.1182/blood-2018-99-113189

Published: 2018

Journal Articles

Therapeutic Targeting of the Histone Ubiquitination-Methylation Axis in T Cell Leukemia

Panagiotis Ntziachristos, PhD, Kelly Arcipowski, PhD, Carlos Alberto Martinez, Yixing Zhu, Andrew G. Volk, PhD, Suresh Kumar, Paul M Thomas, PhD, Pieter Van Vlierberghe, PhD, Nobuko Hijiya, MD, Stacy Marshall, Jack Wang, Jian Wu, Neil L Kelleher, PhD, John Crispino, PhD MBA

Blood (2016) 128 (22): 1532.

https://doi.org/10.1182/blood.V128.22.1532.1532

Published: 2016

Journal Articles

BAP1 Loss Results in EZH2-Dependent Transformation in Myelodysplastic Syndromes

Lindsay M LaFave, PhD, Wendy Béguelin, PhD, Richard Koche, PhD, Matt Teater, Efthymia Papalexi, Barbara Spitzer, MD, Sarah Knutson, PhD, John Campbell, PhD, Heike Keilhack, PhD, Paul M Thomas, PhD, Neil L Kelleher, PhD, Omar Abdel-Wahab, Ari M. Melnick, MD, Scott A. Armstrong, MD PhD, Ross L. Levine, MD

Blood (2015) 126 (23): 713.

https://doi.org/10.1182/blood.V126.23.713.713

Published: 2015

Journal Articles

Tissue factor–positive neutrophils bind to injured endothelial wall and initiate thrombus formation

Roxane Darbousset, Grace M. Thomas, Soraya Mezouar, Corinne Frère, Rénaté Bonier, Nigel Mackman, Thomas Renné, Françoise Dignat-George, Christophe Dubois, Laurence Panicot-Dubois

Blood (2012) 120 (10): 2133–2143.

https://doi.org/10.1182/blood-2012-06-437772

Published: 2012

Includes: Multimedia, Supplemental data

Journal Articles

Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice

Grace M. Thomas, Carla Carbo, Brian R. Curtis, Kimberly Martinod, Irina B. Mazo, Daphne Schatzberg, Stephen M. Cifuni, Tobias A. Fuchs, Ulrich H. von Andrian, John H. Hartwig, Richard H. Aster, Denisa D. Wagner

Blood (2012) 119 (26): 6335–6343.

https://doi.org/10.1182/blood-2012-01-405183

Published: 2012

Includes: Multimedia, Supplemental data

Journal Articles

Extracellular DNA Traps Are Associated with Pathogenesis of TRALI in Humans and Mice

Grace M. Thomas, PhD, Carla Carbo, PhD, Brian Curtis, PhD, Kimberly Martinod, BA, BS, Irina B. Mazo, MD, PhD, Daphne Schatzberg, BS, Stephen M. Cifuni, BS, Tobias A. Fuchs, PhD, Ulrich H. von Andrian, MD, PhD, John H. Hartwig, PhD, Richard H. Aster, MD, Denisa D. Wagner, PhD

Blood (2011) 118 (21): 37.

https://doi.org/10.1182/blood.V118.21.37.37

Published: 2011

Journal Articles

Cancer-Associated Thrombosis: Cancer Cell-Derived Microparticles As a Trigger of Venous Thrombosis in a Mouse Model of Flow Restriction

Grace M. Thomas, PhD, Alexander Brill, MD, PhD, Denisa D. Wagner, PhD

Blood (2011) 118 (21): 34.

https://doi.org/10.1182/blood.V118.21.34.34

Published: 2011

Journal Articles

Phase I Dose-Escalation Study of SCH 900776 in Combination with Cytarabine (Ara-C) in Patients with Acute Leukemia

Brian M. Thomas, MD, Scott H. Kaufmann, MD, PhD, Jacqueline M Greer, RN, Steven D. Gore, MD, Keith W. Pratz, MD, B. Douglas Smith, MD, Karen Mackey, RN, Sabine Loechner, MPA, Jo Ann Horowitz, MD, Judith E. Karp, MD

Blood (2011) 118 (21): 1531.

https://doi.org/10.1182/blood.V118.21.1531.1531

Published: 2011

Journal Articles

The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells

Eva Martinez-Garcia, Relja Popovic, Dong-Joon Min, Steve M. M. Sweet, Paul M. Thomas, Leonid Zamdborg, Aaron Heffner, Christine Will, Laurence Lamy, Louis M. Staudt, David L. Levens, Neil L. Kelleher, Jonathan D. Licht

Blood (2011) 117 (1): 211–220.

https://doi.org/10.1182/blood-2010-07-298349

Published: 2011

Includes: Supplemental data

Journal Articles

Addressing the Issue of the Pathogenesis of Deep Vein Thrombosis In Cancer

Grace M Thomas, PhD, Alexander Brill, M.D., PhD, Daphne Schatzberg, B.S., Denisa D. Wagner, PhD

Blood (2010) 116 (21): 4220.

https://doi.org/10.1182/blood.V116.21.4220.4220

Published: 2010

Journal Articles

Effective Remission Induction for AML Using Two Days of Chemotherapy: Older Patients Tolerate and Respond Equally Well

Neel B. Shah, MD, Melissa L. Larson, MD, Nitin Goyal, Ann M. Thomas, Jamile M. Shammo, MD, John J. Maciejewski, MD, PhD, Stephanie A. Gregory, MD, Parameswaran Venugopal, MD

Blood (2008) 112 (11): 4004.

https://doi.org/10.1182/blood.V112.11.4004.4004

Published: 2008

Journal Articles

Efficacy of a Two Day Induction Regimen for De Novo and Secondary AML with Intermediate and Adverse Cytogenetic Profiles

Melissa L. Larson, MD, Ann M. Thomas, Nitin Goyal, Jamile M. Shammo, MD, John J. Maciejewski, MD, PhD, Stephanie A. Gregory, MD, Parameswaran Venugopal, MD

Blood (2008) 112 (11): 4027.

https://doi.org/10.1182/blood.V112.11.4027.4027

Published: 2008

Journal Articles

Tolerability of An Effective Two Day Induction Regimen for Newly Diagnosed AML

Melissa L. Larson, MD, Nitin Goyal, Ann M. Thomas, Jamile M. Shammo, MD, John J. Maciejewski, MD, PhD, Stephanie A. Gregory, MD, Parameswaran Venugopal, MD

Blood (2008) 112 (11): 4035.

https://doi.org/10.1182/blood.V112.11.4035.4035

Published: 2008

NARROW

Clinical Outcomes of EBV-Positive Compared to EBV-Negative Diffuse Large B Cell Lymphoma in the Modern Era

Longitudinal detection of prion infection in preclinical sheep blood samples compared using 3 assays

PATH-HHT, a Double-Blind, Randomized, Placebo-Controlled Trial in Hereditary Hemorrhagic Telangiectasia Demonstrates That Pomalidomide Reduces Epistaxis and Improves Quality of Life

Risk Assessing Medical Inpatients for Hospital-Acquired Venous Thrombosis: The Medical Inpatients Thrombosis and Hemostasis (MITH) Study

Impaired adhesion of neutrophils expressing Slc44a2/HNA-3b to VWF protects against NETosis under venous shear rates

Development of a Computable Phenotype for Hospital-Acquired Venous Thrombosis: The Medical Inpatient Thrombosis and Hemostasis (MITH) Study

Identification and targeting of novel CDK9 complexes in acute myeloid leukemia

Treatment with Foscarnet after Allogeneic Hematopoietic-Cell Transplant (AlloHCT) Is Associated with Long-Term Loss of Renal Function

Therapeutic Targeting of the Histone Ubiquitination-Methylation Axis in T Cell Leukemia

BAP1 Loss Results in EZH2-Dependent Transformation in Myelodysplastic Syndromes

Tissue factor–positive neutrophils bind to injured endothelial wall and initiate thrombus formation

Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice

Extracellular DNA Traps Are Associated with Pathogenesis of TRALI in Humans and Mice

Cancer-Associated Thrombosis: Cancer Cell-Derived Microparticles As a Trigger of Venous Thrombosis in a Mouse Model of Flow Restriction

Phase I Dose-Escalation Study of SCH 900776 in Combination with Cytarabine (Ara-C) in Patients with Acute Leukemia

The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells

Addressing the Issue of the Pathogenesis of Deep Vein Thrombosis In Cancer

Effective Remission Induction for AML Using Two Days of Chemotherapy: Older Patients Tolerate and Respond Equally Well

Efficacy of a Two Day Induction Regimen for De Novo and Secondary AML with Intermediate and Adverse Cytogenetic Profiles

Tolerability of An Effective Two Day Induction Regimen for Newly Diagnosed AML

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only